| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $8.09M | $14.10M | $14.58M | $12.09M | $12.81M |
| R&D | $1.83M | $5.40M | $6.04M | $4.75M | $2.03M |
| SG&A | $6.26M | $8.70M | $8.53M | $7.34M | $208.27K |
| Operating Income | -$8.09M | -$14.12M | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | $0.00 | – |
| Net Income | -$7.97M | -$14.10M | -$14.58M | -$12.09M | -$12.75M |
| EPS (basic) | -5.3200 | -0.8700 | -1.1500 | -1.1200 | -1.4900 |
| EPS (diluted) | -5.3200 | -0.8700 | -1.1500 | -1.1200 | -1.4900 |
| Shares (diluted) | $1.50M | $16.16M | $12.67M | $10.82M | $8.54M |